News

Evotec SE to Announce Results for the First Quarter 2022 on 11 May 2022

HAMBURG, GERMANY / ACCESSWIRE / May 4, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will…

2 years ago

Umoja Biopharma Presents Data on its Synthetic Cytokine Receptor Platform at the International Society for Cell and Gene Therapy Annual Meeting 2022

RACR-induced cytotoxic innate lymphocytes permit the expansion and differentiation of iPSCs with fewer limitations, leading to a more cost-effective manufacturing…

2 years ago

Marker Therapeutics to Present Four Posters on its T Cell-Based Immunotherapies at the 2022 International Society for Cell & Gene Therapy Annual Meeting

HOUSTON, May 04, 2022 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of…

2 years ago

NATO Center of Excellence for Military Medicine to Study Brain Scientific’s NeuroCap Device

Brain Scientific partner LOK Corporation will illustrate the advantages of expanding EEG access with Brain Scientific’s neurology productsLAKEWOOD RANCH, Fla.,…

2 years ago

Annual General Meeting of Infant Bacterial Therapeutics

At the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) on May 4, 2022, among other things, the following…

2 years ago

Cloud DX Signs Third Paramedical Service Provider with Peterborough County Paramedics

Paramedical Providers bring Remote Patient Monitoring (RPM) to Community CareNews in SummaryPeterborough County is the third Paramedical Provider to sign…

2 years ago

TOWER ONE ANNOUNCES FILING OF ITS Q4 AND YEAR 2021 ANNUAL REPORT

First year with positive EBITDA(1)Miami, FL, May 04, 2022 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF)…

2 years ago

Jupiter Wellness’ to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference

JW-300 Demonstrated Efficacy in the Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo-Controlled Clinical TrialJUPITER, FL / ACCESSWIRE /…

2 years ago

Rezolute, Inc. Announces Closing of Registered Direct Offering

REDWOOD CITY, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing…

2 years ago

Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program

Company Signs Development & Manufacturing Agreement with Safer Medical of Montana for Formulation, Pilot Batches, and Commercial Production of CBD…

2 years ago